12 months of anticoagulation found to improve outcomes in cancer patients with minor blood clots
Twelve months of edoxaban is superior to three months for the reduction of thrombotic events in patients with cancer and distal deep vein thrombosis (DVT), according to late breaking research presented in a Hot Line session ...
Aug 28, 2023
0
1